U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07540416) titled 'Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch' on April 06.
Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of tenecteplase administered 4.5-9 hours after stroke onset (defined as the time the patient was first found with symptoms, including wake-up stroke and unwitnessed stroke) in patients with acute ischemic stroke (AIS) guided by DWI-FLAIR mismatch on MRI. The main questions it aims to answer are:
1. Does tenecteplase improve functional outcomes at 90 days compared with standard treatments in AIS patients administered 4.5-9 hours after stroke onset guided by DWI-FLAIR mi...